2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a is under investigation in clinical trial NCT01668823 (Photodynamic Therapy in Treating Patients With Lung Cancer).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.